Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Selective alpha1a-adrenoceptor blockers described by Merck & Co.

July 10, 1997

Natural products for the treatment of BPH

July 9, 1997

Agents for BPH claimed by Merck & Co.

July 8, 1997

Hemodialyzer efficacy established in patients

July 7, 1997

Synaptic and Merck & Co. prepare selective human alpha1A-adrenoceptor antagonists

July 7, 1997

Shire acquires distribution rights for Urispas from Recordati

July 2, 1997

Joint venture formed to market RenaGel

June 19, 1997

RPR seeks FDA approval for DDAVP tablets for bed-wetting

June 19, 1997

Compounds for urinary incontinence from Kyowa Hakko

June 17, 1997

Multinational trial assesses efficacy and safety of tolterodine for incontinence

June 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...